Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4

Journal of Autoimmunity

Volumn 11, Issue 1, 1998, Pages 53-62

  Bachelez, Hervé ^a   Flageul, Béatrice ^a   Dubertret, Louis ^a   Fraitag, Sylvie ^b   Grossman, Rachel ^a   Brousse, Nicole ^b   Poisson, Dominique ^c   Knowles, Robert W ^d   Wacholtz, Mary C ^d   Haverty, Thomas P ^d   Chatenoud, Lucienne ^b   Bach, Jean François ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Cilag   (France)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

CD4; Immunosuppression; Monoclonal antibody; Psoriasis

Indexed keywords

CD4 ANTIGEN; OKT 4; ORTHOCLONE OKT CDR4A; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; FEMALE; HAIR LOSS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE ACTIVATION;

EID: 0031914851     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0175     Document Type: Article

References (37)

1. Bata-Csorgo Z., Hammerberg C., Voorhees J.J., Cooper K.D. 1995. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol 105: 89S
2. Timonen P., Friend D., Abeywickrama K., Laburte C., Von Gaffenried B., Feutren G. 1990. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br. J. Dermatol. 122 (Suppl 36): 33
3. Higgins E., Munro C., Marks J., Friedmann P.S., Shuster S. 1989. Relapse rates in moderately severe chronic psoriasis treated with cyclosporin A. Br. J. Dermatol. 121: 71
4. Prinz J., Braun-Falco O., Meurer M., Daddona P., Reiter C., Rieber P., Riethmuller G. 1991. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet 338: 320
5. Rizova H., Nicolas J.F., Morel P., Kanitakis J., Demidem A., Revillard J.P., Wijdenes J., Thivolet J., Schmitt D. 1994. The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin. J. Dermatol. Sci. 7: 1
6. Morel P., Revillard J.P., Nicolas J.F., Wijdenes J., Rizova H., Thivolet J. 1992. Anti-CD4 monoclonal antibody therapy in severe psoriasis. J. Autoimmun. 5: 465
7. Thivolet J., Nicolas J.F. 1994. Immunointervention in psoriasis with anti-CD4 antibodies. Int. J. Dermatol. 33: 327
8. + T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc. Natl. Acad. Sci. USA 91: 9282
9. Moss P., Charmley P., Mulvihill, E., Ziegler S., Raugi G.J., Kern D, Piepkorn, M., Gelinas R. 1997. The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. J. Invest. Dermatol. 109: 14-19
10. Vekony M.A., Holder J.E., Lee A.J., Horrocks C., Eperon I.C., Camp R.D. 1997. Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. J. Invest. Dermatol. 109: 5-13
11. Gottlieb S.L., Gilleaudeau P., Johnson R., Estes L., Woodworth T.G., Gottlieb A.B., Krueger J.G. 1995. Response of psoriasis to a lymphocyte-selective toxin (DAB389 IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med. 1: 442
12. Wofsy D., Mayes D.C., Woodcock J., Seaman W.E. 1985. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. J. Immunol. 135: 1698
13. Cosimi A.B., Delmonico EL., Wright J.K., Wee S.L., Preffer F.I., Jolliffe L.K., Colvin R.B. 1990. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 108: 406
14. Shizuru J.A., Seydel K.B., Flavin T.F., Wu A.P., Kong C.C., Hoyt G., Fujimoto N., Billingham M.E., Starnes V.A., Fathman C.G. 1990. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 50: 366
15. Darby C.R., Bushell A., Morris P.J., Wood K.J. 1994. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 57: 1419
16. Pearson T.C., Madsen J.C., Larsen C.P., Morris P.J., Wood K.J. 1992. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 54: 475
17. Qin S.X., Wise M., Cobbold S.P., Leong L., Kong Y.C., Parnes J.R., Waldmann H. 1990. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20: 2737
18. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. 1993. "Infectious" transplantation tolerance. Science 259: 974
19. Brostoff S.W., Mason D.W. 1984. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol. 133: 1938
20. Christadoss P., Dauphinee M.J. 1986 Immunotherapy for myasthenia gravis: a murine model. J. Immunol. 136: 2436
21. Nicolas J.F., Chamchick N., Thivolet J., Wijdenes J., Morel P., Revillard J.P. 1991. CD4 antibody treatment of severe psoriasis. Lancet 338: 321
22. + T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy. J. Rheumatol. 19: 1845
23. Pulito V.L., Roberts V.A., Adair J.R., Rothermel A.L., Collins A.M., Varga S.S., Martocello C., Bodmer M., Jolliffe L.K., Zivin R.A. 1996. Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. J. Immunol. 156: 2840
24. Powelson J.A., Knowles R.W., Delmonico EL., Kawai T., Mourad G., Preffer F.K., Colvin R.B., Cosimi A.B. 1994. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation 57: 788
25. Moreland L.W., Bucy R.P., Knowles R.W., Wacholtz M.C., Haverty T.P., Koopman W.J. 1995. Treating rheumatoid arthritis with a non-depleting anti-CD4 monoclonal antibody (abstract). Arthritis Rheum. 39: S186
26. Delmonico E.L., Cosimi A.B., Kawai T., Cavender D., Lee W.H., Jolliffe L.K., Knowles R.W. 1993. Nonhuman primate responses to murine and humanized OKT4A. Transplantation 55: 722
27. Chatenoud L., Baudrihaye M.F., Chkoff N., Kreis H., Goldstein G., Bach J.F. 1986. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. J. Immunol. 137: 830
28. Wee S., Stroka D.M., D'Souza G., Fuller T.C., Fitzpatrick D.M., Cosimi A.B. 1994. Anti-CD4 mAb therapy significantly delays the alloantibody response in a cynomolgus renal transplant model. Transplantation 58: 261
29. Cooperative Clinical Trials in Transplantation (CCTT) Research Group 1995. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative pilot study (report 1). Transplant. Proc. 27: 863
30. Riechmann L., Clark M., Waldmann H., Winter G. 1988. Reshaping human antibodies for therapy. Nature 332: 323
31. Ellis C.N., Fradin M.S., Messana J.M., Brown M.D., Siegel M.T., Hartley A.H., Rocher L.L., Wheeler S., Hamilton T.A., Parish T.G., et al. 1991. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N. Engl. J. Med. 324: 277
32. Wood G.S., Warner N.L., Warnke R.A. 1983. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J. Immunol. 131: 212
33. Moreland L.W., Pratt P.W., Bucy R.P., Jackson B.S., Feldman J.W, Koopman W.J. 1994. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Arthritis Rheum. 37: 834
34. Chatenoud L., Thervet E., Primo J., Bach J.F. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91: 123
35. Desilva D.R., Urdahl K.B., Jenkins M.K. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147: 3261
36. Schwartz R.H. 1993. Immunological tolerance. In Fundamental Immunology. W.E. Paul, ed. Raven Press, New York, p 677
37. Field E.H., Rouse T.M., Fleming A.L., Jamali I., Cowdery J.S. 1992. Altered IFN-gamma and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody. J. Immunol. 149: 1131-1137